NCT06608719Completed
Retrospective Study on the Safety and Therapeutic/Improvement Effects of Intravenous Administration of SHED-CM for ALS (SHED-CAH2023)
Retrospective Study on the Safety and Therapeutic/Improvement Effects of Intravenous Administration of SHED-CM for ALS
Source: ClinicalTrials.gov · Last updated 23 Sept 2024
Brief summary (registry, in English)
In this study, we will retrospectively evaluate the safety and efficacy of administering SHED-CM for the treatment of ALS.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 24 (actual)
- First submitted
- 18 Jul 2024
- Start date
- 25 Dec 2023
- Primary completion date
- 1 Jul 2024
- Lead sponsor
- Hitonowa Medical
- Diseases
- ALS (motor neurone disease)
- NCT number
- NCT06608719
What you commit to
- Study type: Observational
- Participants enrolled: 24
- From 25 Dec 2023 to the primary completion date, 1 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients who have a tracheostomy at the time of visit.
- Patients who have expressed their refusal to participate in this study.
Who the study is looking for
- patients who visited our clinic between January 1, 2022 and November 30, 2023 and have been diagnosed with ALS
- male and female patients aged between 16 and 90 years old
- ALSFRS-R score of 12 or more at the time of initial visit
Age in the registry: 38 years to 81 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hitonowa Medical Coordinator of this site? Confirm its status | Chiyoda City | Japan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.